Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors

Journal of Cellular Biochemistry

Volumn 109, Issue 4, 2010, Pages 672-682

  Jensen, Eric D ^a   Pham, Lan ^a   Billington Jr , Charles J ^b   Espe, Kelly ^a   Carlson, Ann E ^a   Westendorf, Jennifer J ^c   Petryk, Anna ^b   Gopalakrishnan, Rajaram ^a   Mansky, Kim ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

BMP2; BMPR Type II; Osteoclast; SMAD 1 5 8

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; COLONY STIMULATING FACTOR 1; LENTIVIRUS VECTOR; NOGGIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; AUTOCRINE COMMUNICATION; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS; CELL DIFFERENTIATION; MICE; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; SIGNAL TRANSDUCTION; SMAD PROTEINS; STEM CELLS;

MURINAE;

EID: 77749309997     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22462     Document Type: Article

References (40)

1. Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC. 2000. Essential requirement of BMPs-2/ 4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: Antagonism by noggin. J Bone Miner Res 15:663-673.
2. Anderson HC, Hodges PT, Aguilera XM, Missana L, Moylan PE. 2000. Bone morphogenetic protein (BMP) localization in developing human and rat growth plate, metaphysis, epiphysis, and articular cartilage. J Histochem Cytochem 48:1493-1502.
3. Canalis E, Economides AN, Gazzerro E. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235.
4. Cao X, Chen D. 2005. The BMP signaling and in vivo bone formation. Gene 357:1-8.
5. Cecchini MG, Hofstetter W, Halasy J, Wetterwald A, Felix R. 1997. Role of CSF-1 in bone and bone marrow development. Mol Reprod Dev 46:75-83; discussion 83-4.
6. Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch H. 1990. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 5:781-789.
7. Giannoudis PV, Kanakaris NK, Einhorn TA. 2007. Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: Review of the existing evidence. Osteoporos Int 18:1565-1581.
8. Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L, Chirgwin JM. 2006. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12:6213s-6216s.
9. Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA. 2009. Local communication on and within bone controls bone remodeling. Bone 44:1026-1033.
10. Irie A, Habuchi H, Kimata K, Sanai Y. 2003. Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem Biophys Res Commun 308:858-865.
11. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N. 2001. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 142:3656-3662.
12. Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K. 1995. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 10:1681-1690.
13. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y. 2000. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27:479-486.
14. Kirker-Head CA, Boudrieau RJ, Kraus KH. 2007. Use of bone morphogenetic proteins for augmentation of bone regeneration. J Am Vet Med Assoc 231:1039-1055.
15. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKLRANK interaction. J Exp Med 191:275-286.
16. Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T. 1999. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun 259:97-102.
17. Komarova SV, Smith RJ, Dixon SJ, Sims SM, Wahl LM. 2003. Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. Bone 33:206-215.
18. Oelgeschlager M, Reversade B, Larrain J, Little S, Mullins MC, De Robertis EM. 2003. The pro-BMP activity of Twisted gastrulation is independent of BMP binding. Development 130:4047-4056.
19. Okamoto M, Murai J, Yoshikawa H, Tsumaki N. 2006. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res 21:1022-1033.
20. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath TK, ten Dijke P, Sakou T. 1998. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 22:605-612.
21. Otsuka E, Notoya M, Hagiwara H. 2003. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts. Calcif Tissue Int 73:72-77.
22. Paine-Saunders S, Viviano BL, Economides AN, Saunders S. 2002. Heparan sulfate proteoglycans retain Noggin at the cell surface: A potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem 277: 2089-2096.
23. Paul S, Lee JC, Yeh LC. 2009. A comparative study on BMP-induced osteoclastogenesis and osteoblastogenesis in primary cultures of adult rat bone marrow cells. Growth Factors 27:121-131.
24. Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ. 2008. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci USA 105: 20764-20769.
25. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289:1508-1514.
26. Rodriguez JS, Mansky KC, Jensen ED, Carlson AE, Schwarz T, Pham L, Mackenzie B, Prasad H, Rohrer MD, Petryk A, Gopalakrishnan R. 2009. Enhanced osteoclastogenesis causes osteopenia in Twisted gastrulationdeficient mice through increased BMP signaling. J Bone Miner Res 24: 1917-1926.
27. Roodman GD. 2009. Pathogenesis of myeloma bone disease. Leukemia 23: 435-441.
28. Ross JJ, Shimmi O, Vilmos P, Petryk A, Kim H, Gaudenz K, Hermanson S, Ekker SC, O'Connor MB, Marsh JL. 2001. Twisted gastrulation is a conserved extracellular BMP antagonist. Nature 410:479-483.
29. Sims NA, Gooi JH. 2008. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 19:444-451.
30. Spector JA, Luchs JS, Mehrara BJ, Greenwald JA, Smith LP, Longaker MT. 2001. Expression of bone morphogenetic proteins during membranous bone healing. Plast Reconstr Surg 107:124-134.
31. Tanaka S, Nakamura K, Takahasi N, Suda T. 2005. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 208:30-49.
32. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289:1504-1508.
33. Toth JM, Boden SD, Burkus JK, Badura JM, Peckham SM, McKay WF. 2009. Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment. Spine (Phila Pa 1976) 34:539-550.
34. Vaananen HK, Laitala-Leinonen T. 2008. Osteoclast lineage and function. Arch Biochem Biophys 473:132-138.
35. Wada T, Nakashima T, Hiroshi N, Penninger JM. 2006. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17-25.
36. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, Jr., Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER. 1990. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 87:4828-4832.
37. Wildemann B, Kadow-Romacker A, Lubberstedt M, Raschke M, Haas NP, Schmidmaier G. 2005. Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier. Calcif Tissue Int 76:50-55.
38. Wutzl A, Brozek W, Lernbass I, Rauner M, Hofbauer G, Schopper C, Watzinger F, Peterlik M, Pietschmann P. 2006. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A 77:75-83.
39. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444.
40. Zoricic S, Maric I, Bobinac D, Vukicevic S. 2003. Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. J Anat 202:269-277.